Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome with Respiratory Symptoms

HomeState ResourceEvaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome with Respiratory Symptoms

Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome with Respiratory Symptoms


This study evaluates the safety, tolerability and efficacy of Sarizotan in reducing respiratory abnormalities in Rett syndrome.  Eligibility criteria include girls or boys age 13 or above. Click here to view the study.

University of Alabama, Birmingham
1-205-996-4927
For study information, please contact Jane Lane at [email protected].